Pricing Log in Create free account
Friday 6 November 2026 Export PACS’s income statement to Excel — free account

PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.

Revenue
+11.5%
EPS
+16.4%
Free cash flow
−4.31%
Total debt
+7.48%

Quarter to September 2026, against a year earlier

50.09 0.17 −0.34%
Market cap
$8.0B
P/E
28.6×
Fwd P/E
21.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

PACS Group, Inc. (PACS) SEC filings, changes and red flags

Red flags

  • Material weakness

    PACS Group, Inc.’s 10-Q reports a material weakness in internal control over financial reporting

    The material weaknesses will not be fully remediated until the necessary internal controls have been designed, implemented, tested and determined to be operating effectively for a sufficient period of time.

    10-Q filed · The filing · sec.gov

  • Officer departure

    PACS Group, Inc. reported the departure of an officer or director

    8-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 7 added · 3 removed · 30 modified
P2I1A: no material changes, the filing says 		Material weakness
8-K Nov 3, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 18, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Aug 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 16 added · 3 removed · 34 modified
P2I1A: no material changes, the filing says
8-K Jun 10, 2026 5.07 Submission of matters to a vote of security holders
8-K May 11, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 24, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 4, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 4 added · 39 modified
1A: 18 added · 4 removed · 93 modified
7: 5 added · 51 removed · 52 modified
8-K Feb 26, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 19, 2025 5.07 Submission of matters to a vote of security holders
8-K Nov 26, 2025 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Nov 19, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
10-Q Jun 30, 2025
10-Q Mar 31, 2025
10-K Dec 31, 2024
10-Q Sep 30, 2024
NT 10-Q Sep 30, 2025
8-K Nov 6, 2025 8.01 Other events
8-K Sep 11, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 9, 2025 8.01 Other events
8-K Sep 2, 2025 5.02 Departure or appointment of directors or officers
8-K Nov 6, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Aug 12, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K May 13, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.